Back
Recursion Pharmaceuticals Stock Price Chart
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
RXRX
Recursion Pharmaceuticals
Last Price:
$5.63
Seasonality Move:
6.71%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and RXRX is experiencing slight selling pressure.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.71 | Buy |
| 20-day SMA: | 5.54 | Sell |
| 50-day SMA: | 6.85 | Sell |
| 200-day SMA: | 6.98 | Sell |
| 8-day EMA: | 5.06 | Buy |
| 20-day EMA: | 5.46 | Buy |
| 50-day EMA: | 6.27 | Sell |
| 200-day EMA: | 7.15 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.54 | Sell |
| Relative Strength Index (14 RSI): | 47.95 | Sell |
| Chaikin Money Flow: | -9232901 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Recursion Pharmaceuticals Technical Analysis
| Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 5.51 while RXRX 8-day simple moving average is 4.71, which is a Buy signal.
-
The stock price of RXRX is 5.51 while Recursion Pharmaceuticals 20-day SMA is 5.54, which makes it a Sell.
-
Recursion Pharmaceuticals 50-day simple moving average is 6.85 while RXRX share price is 5.51, making it a Sell technically.
-
RXRX stock price is 5.51 and Recursion Pharmaceuticals 200-day simple moving average is 6.98, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Sell
27
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a SellThe current Recursion Pharmaceuticals [RXRX] share price is $5.51. The Score for RXRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
2.2B
Price in USD:
5.51
Share Volume:
34.5M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
12.36
52-Week Low:
3.79
Sell
27
Recursion Pharmaceuticals (RXRX)
is a Sell
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?The Recursion Pharmaceuticals stock price is 5.51 USD today.
-
Will RXRX stock go up or go down?Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Recursion Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 5.51 while RXRX 8-day exponential moving average is 5.06, which is a Buy signal.
-
The stock price of RXRX is 5.51 while Recursion Pharmaceuticals 20-day EMA is 5.46, which makes it a Buy.
-
Recursion Pharmaceuticals 50-day exponential moving average is 6.27 while RXRX share price is 5.51, making it a Sell technically.
-
RXRX stock price is 5.51 and Recursion Pharmaceuticals 200-day simple moving average is 7.15, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.17 per share, a decrease this year of $0.07 per share, and an increase next year of $0.27 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
-
RXRX Moving Average Covergence Divergence (MACD) indicator is -0.54, suggesting Recursion Pharmaceuticals is a Sell
-
Recursion Pharmaceuticals Relative Strength Index (RSI) is 47.95, which suggest Recursion Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Recursion Pharmaceuticals is ( - ), which suggest Recursion Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Recursion Pharmaceuticals is ( - ), which suggest Recursion Pharmaceuticals is a Buy
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.